Original Investigation

Lymph Node Dissection Guideline Adherence and Survival in Patients With T1N0M0 Lung Adenocarcinoma

JAMA Oncology 10.1001/jamaoncol.2025.5924

January 15, 2026 at 11:00 AM EST

Read the full article

Is guideline-adherent lymph node dissection associated with survival benefit among patients with cT1N0M0 lung adenocarcinoma?In this cohort study of 27 191 patients with cT1N0M0 lung adenocarcinoma from a multicenter clinical database, lymph node dissection adherent with the 3 + 1 or the 6-station standard was associated with survival benefit among patients with adenocarcinoma of high-grade or no lepidic pattern, but not with lepidic without high-grade pattern.These findings suggest that the survival impact of guideline-adherent lymph node dissection differed among patients with adenocarcinomas of different histologic pattern types.

Corresponding Authors: Fengwei Tan, MD, PhD (tanfengwei@cicams.ac.cn), and Jie He, MD, PhD (prof.hejie@gmail.com), Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China.

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks